I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bielo, L. Boscolo
40
results:
Search for persons
X
Format
Online (40)
Mediatypes
Articles (Online) (26)
Bookchapter (Online) (1)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
35P Genomic and clinical landscape of metastatic hormone re..:
Bielo, L. Boscolo
;
Rocco, E. Guerini
;
Trapani, D.
...
ESMO Open. 9 (2024) - p. 103043 , 2024
Link:
https://doi.org/10.1016/..
?
2
95P Italian national policy to access molecular tumor board..:
Crimini, E.
;
Bielo, L. Boscolo
;
Marra, A.
...
ESMO Open. 9 (2024) - p. 102321 , 2024
Link:
https://doi.org/10.1016/..
?
3
98P Cancers of unknown primary (CUP): Real-world clinical o..:
Bielo, L. Boscolo
;
Belli, C.
;
Crimini, E.
...
ESMO Open. 9 (2024) - p. 102324 , 2024
Link:
https://doi.org/10.1016/..
?
4
246P Clinical utility of molecular tumor board in metastati..:
Marra, A.
;
Bielo, L. Boscolo
;
Crimini, E.
...
ESMO Open. 9 (2024) - p. 103267 , 2024
Link:
https://doi.org/10.1016/..
?
5
91P Prevalence of HR-/DDR-genes alterations across sarcoma ..:
Bielo, L. Boscolo
;
Repetto, M.
;
Crimini, E.
...
ESMO Open. 9 (2024) - p. 102317 , 2024
Link:
https://doi.org/10.1016/..
?
6
225P Platinum-based chemotherapy and PARP Inhibitors for BR..:
Valenza, C.
;
Trapani, D.
;
Sposetti, C.
...
ESMO Open. 8 (2023) 1 - p. 101414 , 2023
Link:
https://doi.org/10.1016/..
?
7
88P Evaluation of trending drug targets and technologies in..:
Repetto, M.
;
Crimini, E.
;
Belli, C.
...
ESMO Open. 8 (2023) 1 - p. 100946 , 2023
Link:
https://doi.org/10.1016/..
?
8
P175 Characteristics and Survival Outcomes of Breast Cancer..:
Crimini, E.
;
Repetto, M.
;
Bielo, L. Boscolo
...
The Breast. 68 (2023) - p. S84-S85 , 2023
Link:
https://doi.org/10.1016/..
?
9
71P Molecular Tumor Board at the European Institute of Onco..:
Crimini, E.
;
Repetto, M.
;
Boscolo Bielo, L.
...
ESMO Open. 8 (2023) 1 - p. 100929 , 2023
Link:
https://doi.org/10.1016/..
?
10
The evolving landscape of metastatic HER2-positive, hormone..:
Boscolo Bielo, Luca
;
Trapani, Dario
;
Nicolò, Eleonora
...
Cancer Treatment Reviews. 128 (2024) - p. 102761 , 2024
Link:
https://doi.org/10.1016/..
?
11
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers:..:
Crimini, Edoardo
;
Boscolo Bielo, Luca
;
Berton Giachetti, Pier Paolo Maria
...
Cancers. 16 (2024) 2 - p. 281 , 2024
Link:
https://doi.org/10.3390/..
?
12
Radiation therapy, tissue radiosensitization, and potential..:
Natangelo, Stefano
;
Trapani, Dario
;
Koukoutzeli, Chrysanthi
...
Critical Reviews in Oncology/Hematology. 195 (2024) - p. 104270 , 2024
Link:
https://doi.org/10.1016/..
?
13
Clinical actionability of BRCA2 alterations in uterine leio..:
Boscolo Bielo, Luca
;
Repetto, Matteo
;
Crimini, Edoardo
...
The Oncologist. 29 (2024) 7 - p. 560-565 , 2024
Link:
https://doi.org/10.1093/..
?
14
Cancers of Unknown Primary Origin: Real-World Clinical Outc..:
Boscolo Bielo, Luca
;
Belli, Carmen
;
Crimini, Edoardo
...
The Oncologist. 29 (2024) 6 - p. 504-510 , 2024
Link:
https://doi.org/10.1093/..
?
15
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negat..:
Cantini, Luca
;
Trapani, Dario
;
Guidi, Lorenzo
...
Cancer Treatment Reviews. 123 (2024) - p. 102669 , 2024
Link:
https://doi.org/10.1016/..
1-15